We report a case of severe bilateral knee avascular necrosis in a HIV-positive man receiving ritonavir and inhaled fluticasone. This case highlights the need for a thorough medication history in patients on ritonavir-based antiretroviral therapy, especially where multiple prescribers are involved in the patient's care.
LipworthBJ. Systemic adverse effects of inhaled corticosteroids therapy: a systematic review and meta-analysis. Arch Int Med1999; 159: 941–955.
2.
FoisyMYakiwchukE. Adrenal suppression and Cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med2008; 9: 389–396.
3.
KavianiNBukbergPManessisA. Iatrogenic osteoporosis, bilateral hip osteonecrosis and secondary adrenal suppression in an HIV-infected patient receiving inhaled corticosteroids and ritonavir-boosted HAART. Endocrine Pract2011; 17: 74–78.
4.
GutierrezFPadillaSMasiaM. Osteonecrosis in patients with HIV: clinical epidemiology and natural history in a large case series from Spain. J Acquir Immune Defic Syndr2006; 42: 286–292.
5.
AllisonGTBostromMPGlesbyMJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS2003; 17: 1–9.
KedemEShaharEHassounG. Iatrogenic Cushing’s syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma2010; 47: 830–831.
8.
YoganathanKDavidLWilliamsC. Cushing’s syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection. Int J STD AIDS2012; 23: 520–521.
